1. Home
  2. GHLD vs RLAY Comparison

GHLD vs RLAY Comparison

Compare GHLD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHLD
  • RLAY
  • Stock Information
  • Founded
  • GHLD 1960
  • RLAY 2015
  • Country
  • GHLD United States
  • RLAY United States
  • Employees
  • GHLD N/A
  • RLAY N/A
  • Industry
  • GHLD Finance: Consumer Services
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GHLD Finance
  • RLAY Health Care
  • Exchange
  • GHLD Nasdaq
  • RLAY Nasdaq
  • Market Cap
  • GHLD 1.0B
  • RLAY 1.1B
  • IPO Year
  • GHLD 2020
  • RLAY 2020
  • Fundamental
  • Price
  • GHLD $15.44
  • RLAY $6.64
  • Analyst Decision
  • GHLD Buy
  • RLAY Strong Buy
  • Analyst Count
  • GHLD 5
  • RLAY 9
  • Target Price
  • GHLD $17.50
  • RLAY $20.75
  • AVG Volume (30 Days)
  • GHLD 16.0K
  • RLAY 1.7M
  • Earning Date
  • GHLD 11-06-2024
  • RLAY 10-31-2024
  • Dividend Yield
  • GHLD 3.19%
  • RLAY N/A
  • EPS Growth
  • GHLD N/A
  • RLAY N/A
  • EPS
  • GHLD 0.44
  • RLAY N/A
  • Revenue
  • GHLD $913,919,000.00
  • RLAY $35,208,000.00
  • Revenue This Year
  • GHLD $57.72
  • RLAY N/A
  • Revenue Next Year
  • GHLD $14.50
  • RLAY N/A
  • P/E Ratio
  • GHLD $35.49
  • RLAY N/A
  • Revenue Growth
  • GHLD 15.69
  • RLAY 3637.58
  • 52 Week Low
  • GHLD $9.59
  • RLAY $5.70
  • 52 Week High
  • GHLD $18.26
  • RLAY $12.14
  • Technical
  • Relative Strength Index (RSI)
  • GHLD 42.28
  • RLAY 45.07
  • Support Level
  • GHLD $14.89
  • RLAY $6.55
  • Resistance Level
  • GHLD $15.90
  • RLAY $6.94
  • Average True Range (ATR)
  • GHLD 0.45
  • RLAY 0.39
  • MACD
  • GHLD -0.10
  • RLAY 0.02
  • Stochastic Oscillator
  • GHLD 30.73
  • RLAY 43.29

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: